Citigroup’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,537
Closed -$65.1K 4960
2024
Q1
$65.1K Buy
1,537
+351
+30% +$14.9K ﹤0.01% 3758
2023
Q4
$49.6K Buy
1,186
+1,171
+7,807% +$48.9K ﹤0.01% 3779
2023
Q3
$566 Sell
15
-2,489
-99% -$93.9K ﹤0.01% 4423
2023
Q2
$95K Buy
2,504
+2,441
+3,875% +$92.6K ﹤0.01% 3607
2023
Q1
$1.53K Hold
63
﹤0.01% 4397
2022
Q4
$1.83K Hold
63
﹤0.01% 4494
2022
Q3
$2K Hold
63
﹤0.01% 4746
2022
Q2
$2K Hold
63
﹤0.01% 5137
2022
Q1
$3K Buy
+63
New +$3K ﹤0.01% 5181
2021
Q4
Sell
-4,473
Closed -$285K 5276
2021
Q3
$285K Buy
4,473
+3,900
+681% +$248K ﹤0.01% 3208
2021
Q2
$41K Sell
573
-21,341
-97% -$1.53M ﹤0.01% 4247
2021
Q1
$1.62M Buy
21,914
+614
+3% +$45.3K ﹤0.01% 2059
2020
Q4
$1.56M Sell
21,300
-9,800
-32% -$720K ﹤0.01% 1853
2020
Q3
$1.71M Sell
31,100
-200
-0.6% -$11K ﹤0.01% 1600
2020
Q2
$2.08M Hold
31,300
﹤0.01% 1598
2020
Q1
$1.92M Buy
+31,300
New +$1.92M ﹤0.01% 1411
2019
Q4
Sell
-394
Closed -$30K 5220
2019
Q3
$30K Buy
+394
New +$30K ﹤0.01% 4048
2018
Q3
Sell
-29
Closed -$3K 5157
2018
Q2
$3K Buy
29
+20
+222% +$2.07K ﹤0.01% 4830
2018
Q1
$1K Sell
9
-530
-98% -$58.9K ﹤0.01% 4860
2017
Q4
$56K Sell
539
-4,052
-88% -$421K ﹤0.01% 3747
2017
Q3
$517K Sell
4,591
-3,541
-44% -$399K ﹤0.01% 2402
2017
Q2
$911K Sell
8,132
-968
-11% -$108K ﹤0.01% 2042
2017
Q1
$1.06M Buy
9,100
+1,440
+19% +$168K ﹤0.01% 1875
2016
Q4
$807K Buy
7,660
+4,010
+110% +$422K ﹤0.01% 2546
2016
Q3
$403K Buy
3,650
+2,234
+158% +$247K ﹤0.01% 2579
2016
Q2
$206K Sell
1,416
-1,141
-45% -$166K ﹤0.01% 2847
2016
Q1
$366K Sell
2,557
-388
-13% -$55.5K ﹤0.01% 2969
2015
Q4
$455K Sell
2,945
-1,629
-36% -$252K ﹤0.01% 2423
2015
Q3
$653K Buy
4,574
+2,083
+84% +$297K ﹤0.01% 2016
2015
Q2
$358K Buy
2,491
+2,476
+16,507% +$356K ﹤0.01% 2379
2015
Q1
$2K Buy
+15
New +$2K ﹤0.01% 5252
2014
Q2
Sell
-227
Closed -$25K 5665
2014
Q1
$25K Buy
+227
New +$25K ﹤0.01% 4378